Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Sherr

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
BMC Medical Genomics|August 1, 2016
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancerHsiao-Rong Chen, David H Sherr, Zhenjun Hu, et al.
Journal of Cellular Biochemistry|February 7, 2008
NF-kappaB and epithelial to mesenchymal transition of cancerChengyin Min, Sean F Eddy, David H Sherr, et al.
Biochemical and Biophysical Research Communications|February 14, 2006
CYP1A1 in polycyclic aromatic hydrocarbon-induced B lymphocyte growth suppressionLenka L Allan, Jennifer J Schlezinger, Maryam Shansab, et al.
Environmental Health : a Global Access Science Source|December 18, 2003
Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology studyBrenda A Jensen, Rebecca J Leeman, Jennifer J Schlezinger, et al.
Cancer Research|March 3, 2006
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaBSangmin Ryan Shin, Nuria Sánchez-Velar, David H Sherr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 3, 2007
An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cellsJennifer J Schlezinger, Jessica K Emberley, Stephanie L Bissonnette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathwaysStephanie L Bissonnette, Jessica E Teague, David H Sherr, et al.
Stem Cells International|May 6, 2016
Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human DevelopmentBrenden W Smith, Elizabeth A Stanford, David H Sherr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2010
Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signalingJessica E Teague, Heui-Young Ryu, Michael Kirber, et al.
Nature Reviews. Drug Discovery|April 17, 2025
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulationCarolina M Polonio, Kimberly A McHale, David H Sherr, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
BMC Medical Genomics|August 1, 2016
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancerHsiao-Rong Chen, David H Sherr, Zhenjun Hu, et al.
Journal of Cellular Biochemistry|February 7, 2008
NF-kappaB and epithelial to mesenchymal transition of cancerChengyin Min, Sean F Eddy, David H Sherr, et al.
Biochemical and Biophysical Research Communications|February 14, 2006
CYP1A1 in polycyclic aromatic hydrocarbon-induced B lymphocyte growth suppressionLenka L Allan, Jennifer J Schlezinger, Maryam Shansab, et al.
Environmental Health : a Global Access Science Source|December 18, 2003
Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology studyBrenda A Jensen, Rebecca J Leeman, Jennifer J Schlezinger, et al.
Cancer Research|March 3, 2006
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaBSangmin Ryan Shin, Nuria Sánchez-Velar, David H Sherr, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 3, 2007
An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cellsJennifer J Schlezinger, Jessica K Emberley, Stephanie L Bissonnette, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathwaysStephanie L Bissonnette, Jessica E Teague, David H Sherr, et al.
Stem Cells International|May 6, 2016
Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human DevelopmentBrenden W Smith, Elizabeth A Stanford, David H Sherr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 20, 2010
Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signalingJessica E Teague, Heui-Young Ryu, Michael Kirber, et al.
Nature Reviews. Drug Discovery|April 17, 2025
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulationCarolina M Polonio, Kimberly A McHale, David H Sherr, et al.
Pageof 8